$SMLR
Semler Scientific, Inc.

2023 Q3 Form 10-Q Financial Statement

#000155485923000053 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $16.32M $18.61M
YoY Change 16.15% 25.47%
Cost Of Revenue $1.111M $1.219M
YoY Change -2.37% 26.58%
Gross Profit $15.21M $17.39M
YoY Change 17.79% 25.39%
Gross Profit Margin 93.19% 93.45%
Selling, General & Admin $7.133M $8.444M
YoY Change -0.9% 10.92%
% of Gross Profit 46.91% 48.57%
Research & Development $1.170M $1.762M
YoY Change -5.95% 64.06%
% of Gross Profit 7.69% 10.13%
Depreciation & Amortization $160.0K $150.0K
YoY Change 4.58% -2.6%
% of Gross Profit 1.05% 0.86%
Operating Expenses $7.133M $8.444M
YoY Change -0.9% 10.92%
Operating Profit $6.299M $7.180M
YoY Change 41.01% 38.66%
Interest Expense $690.0K $486.0K
YoY Change 403.65% 3638.46%
% of Operating Profit 10.95% 6.77%
Other Income/Expense, Net $689.0K $486.0K
YoY Change 414.18% 3638.46%
Pretax Income $6.988M $7.666M
YoY Change 51.88% 47.68%
Income Tax $1.474M $1.787M
% Of Pretax Income 21.09% 23.31%
Net Earnings $5.514M $5.879M
YoY Change 50.04% 44.31%
Net Earnings / Revenue 33.8% 31.6%
Basic Earnings Per Share $0.82 $0.88
Diluted Earnings Per Share $0.71 $0.75
COMMON SHARES
Basic Shares Outstanding 6.856M 6.851M
Diluted Shares Outstanding 7.818M 7.867M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.03M $51.83M
YoY Change 23.05% 29.46%
Cash & Equivalents $37.50M $39.50M
Short-Term Investments $18.53M $12.33M
Other Short-Term Assets $1.950M $2.418M
YoY Change -0.51% -12.64%
Inventory $439.0K $476.0K
Prepaid Expenses
Receivables $5.966M $6.032M
Other Receivables $0.00 $0.00
Total Short-Term Assets $64.38M $60.75M
YoY Change 24.57% 24.32%
LONG-TERM ASSETS
Property, Plant & Equipment $3.260M $3.687M
YoY Change 24.38% 39.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $6.280M $5.783M
YoY Change 214.0% 189.15%
Other Assets $2.744M $2.736M
YoY Change 21.04% 19.37%
Total Long-Term Assets $15.07M $14.71M
YoY Change 63.06% 67.76%
TOTAL ASSETS
Total Short-Term Assets $64.38M $60.75M
Total Long-Term Assets $15.07M $14.71M
Total Assets $79.44M $75.46M
YoY Change 30.41% 30.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $300.0K $509.0K
YoY Change -37.89% 9.94%
Accrued Expenses $6.998M $8.243M
YoY Change 5.19% 57.4%
Deferred Revenue $1.120M $1.188M
YoY Change -3.28% 21.1%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.577M $10.08M
YoY Change 2.29% 49.09%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $93.00K $116.0K
YoY Change -48.9% -42.86%
Total Long-Term Liabilities $93.00K $116.0K
YoY Change -48.9% -42.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.577M $10.08M
Total Long-Term Liabilities $93.00K $116.0K
Total Liabilities $8.670M $10.20M
YoY Change 1.2% 46.41%
SHAREHOLDERS EQUITY
Retained Earnings $55.58M $50.07M
YoY Change 54.38% 54.87%
Common Stock $7.000K $7.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $70.77M $65.26M
YoY Change
Total Liabilities & Shareholders Equity $79.44M $75.46M
YoY Change 30.41% 30.93%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $5.514M $5.879M
YoY Change 50.04% 44.31%
Depreciation, Depletion And Amortization $160.0K $150.0K
YoY Change 4.58% -2.6%
Cash From Operating Activities $4.830M $11.20M
YoY Change -39.78% 79.71%
INVESTING ACTIVITIES
Capital Expenditures $150.0K $295.0K
YoY Change -130.55% -149.0%
Acquisitions
YoY Change
Other Investing Activities -$6.630M $25.26M
YoY Change -2242.83%
Cash From Investing Activities -$6.780M $24.97M
YoY Change 1280.86% -1501.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -50.00K -1.975M
YoY Change -97.53% -30.56%
NET CHANGE
Cash From Operating Activities 4.830M 11.20M
Cash From Investing Activities -6.780M 24.97M
Cash From Financing Activities -50.00K -1.975M
Net Change In Cash -2.000M 34.19M
YoY Change -136.33% 2030.22%
FREE CASH FLOW
Cash From Operating Activities $4.830M $11.20M
Capital Expenditures $150.0K $295.0K
Free Cash Flow $4.680M $10.90M
YoY Change -45.02% 59.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001554859
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36305
dei Entity Registrant Name
EntityRegistrantName
SEMLER SCIENTIFIC, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1367393
dei Entity Address Address Line1
EntityAddressAddressLine1
2340-2348 Walsh Avenue, Suite 2344
dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Clara
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95051
dei City Area Code
CityAreaCode
877
dei Local Phone Number
LocalPhoneNumber
774-4211
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
SMLR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6855956
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18605000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14828000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36811000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28845000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
1219000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
963000
us-gaap Cost Of Revenue
CostOfRevenue
2488000
us-gaap Cost Of Revenue
CostOfRevenue
1932000
CY2023Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1762000
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1074000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3392000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2200000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4985000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4201000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10177000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8878000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3459000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3412000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7318000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6715000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
11425000
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
9650000
us-gaap Costs And Expenses
CostsAndExpenses
23375000
us-gaap Costs And Expenses
CostsAndExpenses
19725000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
7180000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5178000
us-gaap Operating Income Loss
OperatingIncomeLoss
13436000
us-gaap Operating Income Loss
OperatingIncomeLoss
9120000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
597000
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
13000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1080000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14000
CY2023Q2 smlr Fair Value Adjustment Of Notes Held For Investment
FairValueAdjustmentOfNotesHeldForInvestment
111000
smlr Fair Value Adjustment Of Notes Held For Investment
FairValueAdjustmentOfNotesHeldForInvestment
217000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
486000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
863000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7666000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5191000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14299000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9134000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1787000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1117000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3451000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1700000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
5879000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
4074000
us-gaap Net Income Loss
NetIncomeLoss
10848000
us-gaap Net Income Loss
NetIncomeLoss
7434000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.10
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6707341
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6761050
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6704306
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6769552
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7867001
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8029302
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7887584
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8071509
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39495000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23014000
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
12330000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
20073000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
154000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
109000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6032000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3884000
CY2023Q2 us-gaap Inventory Net
InventoryNet
476000
CY2022Q4 us-gaap Inventory Net
InventoryNet
469000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2418000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1468000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
60751000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
48908000
CY2023Q2 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
2891000
CY2022Q4 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
2478000
CY2023Q2 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
796000
CY2022Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
667000
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
821000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
821000
CY2023Q2 us-gaap Notes Receivable Fair Value Disclosure
NotesReceivableFairValueDisclosure
3962000
CY2022Q4 us-gaap Notes Receivable Fair Value Disclosure
NotesReceivableFairValueDisclosure
3679000
CY2023Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
4962000
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
4679000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2736000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2842000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2505000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2298000
CY2023Q2 us-gaap Assets
Assets
75462000
CY2022Q4 us-gaap Assets
Assets
62693000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
509000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
835000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8243000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4748000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1188000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1160000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
143000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
114000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10083000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6857000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
116000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
160000
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
116000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
160000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6923446
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6906544
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6709024
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6692122
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
214422
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
214422
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
7000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15188000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16449000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
50068000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39220000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
65263000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
55676000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
75462000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62693000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
49392000
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2846000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
45000
CY2022Q2 smlr Taxes Paid Related To Net Share Settlement Of Equity Awards
TaxesPaidRelatedToNetShareSettlementOfEquityAwards
-8000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
4074000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
50670000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
45547000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2945000
us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
673000
smlr Taxes Paid Related To Net Share Settlement Of Equity Awards
TaxesPaidRelatedToNetShareSettlementOfEquityAwards
-114000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
72000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3000
us-gaap Net Income Loss
NetIncomeLoss
7434000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
50670000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
61201000
CY2023Q2 smlr Adjustments To Additional Paid In Capital Repurchase Of Warrants
AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants
1949000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
152000
CY2023Q2 smlr Taxes Paid Related To Net Share Settlement Of Equity Awards
TaxesPaidRelatedToNetShareSettlementOfEquityAwards
-27000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
5879000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
65263000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
55676000
smlr Adjustments To Additional Paid In Capital Repurchase Of Warrants
AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants
1949000
us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
846000
smlr Taxes Paid Related To Net Share Settlement Of Equity Awards
TaxesPaidRelatedToNetShareSettlementOfEquityAwards
-172000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14000
us-gaap Net Income Loss
NetIncomeLoss
10848000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
65263000
us-gaap Profit Loss
ProfitLoss
10848000
us-gaap Profit Loss
ProfitLoss
7434000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
279000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
309000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-207000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-160000
us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-114000
us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-215000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
92000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
38000
smlr Fair Value Adjustment Of Notes Held For Investment
FairValueAdjustmentOfNotesHeldForInvestment
217000
us-gaap Debt Securities Trading Realized Gain
DebtSecuritiesTradingRealizedGain
237000
us-gaap Share Based Compensation
ShareBasedCompensation
860000
us-gaap Share Based Compensation
ShareBasedCompensation
676000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2240000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1962000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-26000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
950000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1276000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-106000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1960000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-326000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3495000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1800000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
13000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
20000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12057000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7732000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
260000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
258000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
500000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
1179000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
57707000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
49728000
us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
674000
us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
600000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6545000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2037000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
172000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
114000
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
1949000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2945000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
72000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2121000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2987000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16481000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2708000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23014000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37323000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39495000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40031000
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">1</b><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">.</b></span><b style="font-weight:bold;">Basis of Presentation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">Semler Scientific, Inc., a Delaware corporation (“Semler” or “the Company”), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 23, 2023 (the “Annual Report”). In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Credit Losses on Financial Instruments</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"></span>In accordance with Accounting Standards Update (“ASU”) No. 2016-13<i style="font-style:italic;">, Financial Instruments-Credit Losses (Topic 326):</i> <i style="font-style:italic;">Measurement of Credit Losses on Financial Instruments (“</i>Toic 326”), the Company periodically reviews the financial assets for credit losses. Financial instruments include cash, cash equivalents, marketable and non-marketable securities, and accounts receivable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"></span>In determing the amount of the allowance for credit losses, the Company considers historical collectability based on past due status and make judgments about the creditworthiness of customers based on ongoing credit evaluations. The Company also considers customer-specific information, current market conditions, and reasonable and supportable forecasts of future economic conditions. Any credit loss is recorded as a charge to other income, net, not to exceed the amount of the unrealized loss. Unrealized losses other than the credit loss are recognized in accumulated other comprehensive income (“AOCI”). If the Company has an intent to sell, or if it is more likely than not that the Company will be required to sell a debt security in an unrealized loss position before recovery of its amortized cost basis, the Company will write down the security to its fair value and record the corresponding charge as a component of other income, net. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;background:#ffffff;margin:0pt;"><span style="font-size:13.5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Recently Issued Accounting Pronouncements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-indent:0pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Accounting Pronouncements Recently Adopted</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span>In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, <i style="font-style:italic;">Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments </i>(“Topic 326”)<i style="font-style:italic;">.</i> This ASU requires timelier recording of credit losses on loans and other financial instruments held. Instead of reserves based on a current probability analysis, Topic 326 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. All organizations will now use forward-looking information to better inform their credit loss estimates. Topic 326 requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. These disclosures include qualitative and quantitative requirements that provide information about the amounts recorded in the financial statements. In addition, Topic 326 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. In April 2019, the FASB issued ASU No. 2019-04, <i style="font-style:italic;">Codification Improvements to Topic 326 Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825,</i> <i style="font-style:italic;">Financial Instruments</i>, to introduce amendments which will affect the recognition and measurement of financial instruments, including derivatives and hedging. In May 2019, the FASB issued ASU No. 2019-05, <i style="font-style:italic;">Financial Instruments – Credit Losses (Topic 326); </i>Targeted Transition Relief. The amendments in this ASU provide entities that have certain instruments within the scope of Subtopic 326-20 with an option to irrevocably elect the fair value option in Subtopic 825-10, applied on an instrument-by-instrument basis for eligible instruments upon adoption of Topic 326. This standard and related amendments are effective for the Company’s fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted this ASU prospectively effective January 1, 2023 and determined that the adoption of this new accounting standard did not have a material impact on its financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span>In March 2020, FASB issued ASU No. 2020-03, <i style="font-style:italic;">Codification Improvements to Financial Instruments</i>. This ASU improves and clarifies various financial instruments topics, including the current expected credit losses standard issued in 2016 (ASU No. 2016-13). The ASU includes seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments have different effective dates. The issues 1-5 are conforming amendments, which are effective upon issuance of this final update. The Company determined that issues 1-5 have no impact on its financials. The amendments related to issue 6 and 7 effect ASU No. 2016-13, <i style="font-style:italic;">Financial instruments – credit losses (Topic 326): measurement of credit losses on financial statements</i>. Effective dates of issue 6 and 7 are the same as the effective date of ASU No. 2016-13. The Company adopted this ASU prospectively effective January 1, 2023 and determined that the adoption of this new accounting standard did not have a material impact on its financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span>In October 2021, the FASB issued ASU No. 2021-08, <i style="font-style:italic;">Business Combinations (Topic 805):</i> A<i style="font-style:italic;">ccounting for Contract Assets and Contract Liabilities from Contracts with Customers</i>. This ASU improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. For public business entities, this guidance will be effective for fiscal years beginning after December 15, 2022 and for interim periods within those fiscal years. This ASU should be applied prospectively to all business combinations in the year of adoption. The Company adopted this ASU prospectively effective January 1, 2023 and determined that the adoption of this new accounting standard did not have a material impact on its financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span>In March 2022, the FASB issued ASU No. 2022-02, <i style="font-style:italic;">Financial Instruments-Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures, </i>which<i style="font-style:italic;"> </i>eliminates the troubled debt restructuring accounting model in Accounting Standards Codification (“ASC”) 310-40 for creditors that have adopted the guidance on measurement of credit losses in ASU 2016-13. Additionally, the ASU requires the public business entities to disclose current period gross write-offs by year of origination for financing receivables and net investments in leases as part of their vintage disclosures under ASC 326. For entities that have adopted the amendments in ASU 2026-13, the amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. For entities that have not yet adopted the amendments in ASU 2016-13, the effective dates are the same as effective dates in ASU 2016-13. The Company adopted this ASU prospectively effective January 1, 2023 and determined that the adoption of this new accounting standard did not have a material impact on its financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:10pt;visibility:hidden;">​</span></p>
CY2023Q2 smlr Revenue Recognition From Variable License Fee Contracts
RevenueRecognitionFromVariableLicenseFeeContracts
8376000
CY2022Q2 smlr Revenue Recognition From Variable License Fee Contracts
RevenueRecognitionFromVariableLicenseFeeContracts
6012000
smlr Revenue Recognition From Variable License Fee Contracts
RevenueRecognitionFromVariableLicenseFeeContracts
16938000
smlr Revenue Recognition From Variable License Fee Contracts
RevenueRecognitionFromVariableLicenseFeeContracts
11855000
CY2023Q2 smlr Revenue Recognition From Sales Of Hardware And Equipment Accessories
RevenueRecognitionFromSalesOfHardwareAndEquipmentAccessories
611000
CY2022Q2 smlr Revenue Recognition From Sales Of Hardware And Equipment Accessories
RevenueRecognitionFromSalesOfHardwareAndEquipmentAccessories
268000
smlr Revenue Recognition From Sales Of Hardware And Equipment Accessories
RevenueRecognitionFromSalesOfHardwareAndEquipmentAccessories
951000
smlr Revenue Recognition From Sales Of Hardware And Equipment Accessories
RevenueRecognitionFromSalesOfHardwareAndEquipmentAccessories
553000
CY2023Q2 us-gaap Inventory Net
InventoryNet
476000
CY2022Q4 us-gaap Inventory Net
InventoryNet
469000
CY2023Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
9618000
CY2022Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
8548000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
18922000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
16437000
CY2023Q2 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
3998000
CY2022Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
3702000
CY2023Q2 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
1107000
CY2022Q4 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
1224000
CY2023Q2 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
2891000
CY2022Q4 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
2478000
CY2023Q2 us-gaap Operating Leases Income Statement Depreciation Expense On Property Subject To Or Held For Lease
OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease
77000
CY2022Q2 us-gaap Operating Leases Income Statement Depreciation Expense On Property Subject To Or Held For Lease
OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease
103000
us-gaap Operating Leases Income Statement Depreciation Expense On Property Subject To Or Held For Lease
OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease
147000
us-gaap Operating Leases Income Statement Depreciation Expense On Property Subject To Or Held For Lease
OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease
212000
CY2023Q2 smlr Assets For Lease Reduction To Accumulated Depreciation
AssetsForLeaseReductionToAccumulatedDepreciation
67000
CY2022Q2 smlr Assets For Lease Reduction To Accumulated Depreciation
AssetsForLeaseReductionToAccumulatedDepreciation
57000
smlr Assets For Lease Reduction To Accumulated Depreciation
AssetsForLeaseReductionToAccumulatedDepreciation
264000
smlr Assets For Lease Reduction To Accumulated Depreciation
AssetsForLeaseReductionToAccumulatedDepreciation
147000
CY2023Q2 us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-36000
CY2022Q2 us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-141000
us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-114000
us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-215000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10D
CY2023Q2 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
1467000
CY2022Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
1206000
CY2023Q2 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
671000
CY2022Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
539000
CY2023Q2 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
796000
CY2022Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
667000
CY2023Q2 us-gaap Depreciation Excluding Lessor Asset Under Operating Lease
DepreciationExcludingLessorAssetUnderOperatingLease
73000
CY2022Q2 us-gaap Depreciation Excluding Lessor Asset Under Operating Lease
DepreciationExcludingLessorAssetUnderOperatingLease
51000
us-gaap Depreciation Excluding Lessor Asset Under Operating Lease
DepreciationExcludingLessorAssetUnderOperatingLease
132000
us-gaap Depreciation Excluding Lessor Asset Under Operating Lease
DepreciationExcludingLessorAssetUnderOperatingLease
97000
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
821000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
821000
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0
CY2022 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0
CY2023Q2 us-gaap Trading Securities Debt
TradingSecuritiesDebt
12330000
CY2023Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3962000
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
16292000
CY2022Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
20073000
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3679000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
23752000
CY2023Q2 smlr Equity Securities Number Of Privately Held Companies
EquitySecuritiesNumberOfPrivatelyHeldCompanies
2
CY2022Q4 smlr Equity Securities Number Of Privately Held Companies
EquitySecuritiesNumberOfPrivatelyHeldCompanies
2
CY2023Q2 us-gaap Debt Securities
DebtSecurities
3962000
CY2022Q4 us-gaap Debt Securities
DebtSecurities
3679000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
38053000
CY2023Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
4962000
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
4679000
CY2023Q2 smlr Debt Security Interest Income
DebtSecurityInterestIncome
118000
CY2022Q2 smlr Debt Security Interest Income
DebtSecurityInterestIncome
3000
smlr Debt Security Interest Income
DebtSecurityInterestIncome
227000
smlr Debt Security Interest Income
DebtSecurityInterestIncome
3000
CY2023Q2 smlr Debt Security Changes In Fair Value
DebtSecurityChangesInFairValue
111000
smlr Debt Security Changes In Fair Value
DebtSecurityChangesInFairValue
217000
CY2023Q2 smlr Prepaid Licenses Noncurrent
PrepaidLicensesNoncurrent
2424000
CY2022Q4 smlr Prepaid Licenses Noncurrent
PrepaidLicensesNoncurrent
2490000
CY2023Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
312000
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
352000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2736000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2842000
CY2021Q2 smlr Agreement Term
AgreementTerm
P5Y
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
192000
CY2023Q2 smlr Miscellaneous Receivables
MiscellaneousReceivables
100000
CY2023Q2 smlr Long Term Deposits
LongTermDeposits
20000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
233000
CY2022Q4 smlr Miscellaneous Receivables
MiscellaneousReceivables
100000
CY2022Q4 smlr Long Term Deposits
LongTermDeposits
19000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1287847
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.44
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y6M10D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
29381000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1284267
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3865000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2467000
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3824000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1923000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
554000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
358000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8243000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4748000
CY2023Q2 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
10620000
CY2023Q2 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
41205000
CY2020Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P61M
CY2023Q2 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P2Y3M
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
false
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
22000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
22000
us-gaap Operating Lease Cost
OperatingLeaseCost
44000
us-gaap Operating Lease Cost
OperatingLeaseCost
44000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.37
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y6M3D
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7867001
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
45000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
93000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
71000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
209000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
203000
CY2023Q2 smlr Operating Lease Expenses In Excess Of Cash Payments
OperatingLeaseExpensesInExcessOfCashPayments
11000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
192000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
192000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
87000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
116000
CY2023Q2 us-gaap Lease Practical Expedient Lessor Single Lease Component
LeasePracticalExpedientLessorSingleLeaseComponent
true
CY2022Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2023Q2 smlr Income Taxes Receivable Cares Act
IncomeTaxesReceivableCaresAct
1240000
smlr Employee Retention Payroll Tax Credit Claimed Cares Act
EmployeeRetentionPayrollTaxCreditClaimedCaresAct
0
CY2023Q2 smlr Employee Retention Payroll Tax Credit Claimed Cares Act
EmployeeRetentionPayrollTaxCreditClaimedCaresAct
0
CY2022 smlr Employee Retention Payroll Tax Credit Claimed Cares Act
EmployeeRetentionPayrollTaxCreditClaimedCaresAct
0
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
20000000.0
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
148500
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4991000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
21923
smlr Share Based Payment Arrangement Shares Issued Net Of Shares For Tax Withholdings
ShareBasedPaymentArrangementSharesIssuedNetOfSharesForTaxWithholdings
16902
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
798000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
9610
smlr Share Based Compensation Arrangement By Share Based Payment Award Number Of Non Employees
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfNonEmployees
1
smlr Share Based Payment Arrangement Shares Issued Net Of Shares For Tax Withholdings
ShareBasedPaymentArrangementSharesIssuedNetOfSharesForTaxWithholdings
7900
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
673000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1287847
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.44
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
29381000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
159000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
48000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
860000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
676000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1787000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1117000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3451000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1700000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2331
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2413
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2152
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1862
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
447000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
401000
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
56000
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
30000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6707341
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5879000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6761050
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4074000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
CY2023Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
39292
CY2023Q2 smlr Amount Of Dilutive Securities Common Stock Warrants
AmountOfDilutiveSecuritiesCommonStockWarrants
0
CY2022Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
67434
CY2022Q2 smlr Amount Of Dilutive Securities Common Stock Warrants
AmountOfDilutiveSecuritiesCommonStockWarrants
0
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1120368
CY2023Q2 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1200818
CY2022Q2 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
5879000
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8029302
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
4074000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6704306
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10848000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.62
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6769552
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7434000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.10
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
58083
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
69637
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1125195
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1232320
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7887584
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
10848000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.38
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8071509
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
7434000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001554859-23-000053-index-headers.html Edgar Link pending
0001554859-23-000053-index.html Edgar Link pending
0001554859-23-000053.txt Edgar Link pending
0001554859-23-000053-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
smlr-20230630.xsd Edgar Link pending
smlr-20230630x10q.htm Edgar Link pending
smlr-20230630xex10d3.htm Edgar Link pending
smlr-20230630xex10d4.htm Edgar Link pending
smlr-20230630xex31d1.htm Edgar Link pending
smlr-20230630xex31d2.htm Edgar Link pending
smlr-20230630xex32d1.htm Edgar Link pending
smlr-20230630_def.xml Edgar Link unprocessable
smlr-20230630_cal.xml Edgar Link unprocessable
smlr-20230630_lab.xml Edgar Link unprocessable
smlr-20230630_pre.xml Edgar Link unprocessable
smlr-20230630x10q_htm.xml Edgar Link completed